Stockscreener 앱 받기
6.81
2.16%
-0.15
시간 외 거래:
6.82
0.01
+0.15%
전일 마감가:
$6.96
열려 있는:
$6.87
하루 거래량:
3.07M
Relative Volume:
0.64
시가총액:
$1.24B
수익:
$2.51B
순이익/손실:
$-171.15M
주가수익비율:
-7.0694
EPS:
-0.9633
순현금흐름:
$122.59M
1주 성능:
-4.49%
1개월 성능:
-26.54%
6개월 성능:
+46.45%
1년 성능:
-6.71%
1일 변동 폭
$6.79
$6.955
1주일 범위
$6.55
$7.185
52주 변동 폭
$4.40
$9.8868
텔라닥 헬스 Stock (TDOC) Company Profile
명칭
Teladoc Health Inc
전화
(203) 635-2002
주소
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, TEM, HQY, TXG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.81 | 1.22B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
텔라닥 헬스 Stock (TDOC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-02-26 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-07-25 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Buy |
| 2024-09-17 | 재확인 | Jefferies | Hold |
| 2024-02-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-17 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-04-12 | 개시 | Stephens | Equal-Weight |
| 2023-02-23 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | 업그레이드 | Guggenheim | Sell → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-17 | 다운그레이드 | Guggenheim | Neutral → Sell |
| 2022-08-12 | 개시 | DA Davidson | Buy |
| 2022-08-02 | 다운그레이드 | Berenberg | Buy → Hold |
| 2022-08-02 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-07-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-28 | 다운그레이드 | Needham | Buy → Hold |
| 2022-07-06 | 재확인 | BofA Securities | Neutral |
| 2022-05-05 | 다운그레이드 | Argus | Buy → Hold |
| 2022-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-28 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-04-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-04-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-03 | 업그레이드 | Argus | Hold → Buy |
| 2022-02-23 | 재확인 | BofA Securities | Neutral |
| 2022-02-23 | 재확인 | Craig Hallum | Hold |
| 2022-02-23 | 재확인 | Evercore ISI | In-line |
| 2022-02-23 | 재확인 | Goldman | Buy |
| 2022-02-23 | 재확인 | JP Morgan | Overweight |
| 2022-02-23 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | 재확인 | Needham | Buy |
| 2022-02-23 | 재확인 | Oppenheimer | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-08 | 재확인 | Piper Sandler | Overweight |
| 2021-12-02 | 재개 | Jefferies | Hold |
| 2021-11-22 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-28 | 재확인 | Barclays | Equal Weight |
| 2021-10-28 | 재확인 | BofA Securities | Neutral |
| 2021-10-28 | 재확인 | Canaccord Genuity | Buy |
| 2021-10-28 | 재확인 | Citigroup | Buy |
| 2021-10-28 | 재확인 | Craig Hallum | Hold |
| 2021-10-28 | 재확인 | Needham | Buy |
| 2021-10-28 | 재확인 | Oppenheimer | Outperform |
| 2021-10-28 | 재확인 | Piper Sandler | Overweight |
| 2021-10-28 | 재확인 | UBS | Neutral |
| 2021-10-19 | 개시 | Wells Fargo | Overweight |
| 2021-08-02 | 다운그레이드 | Argus | Buy → Hold |
| 2021-07-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-04-15 | 개시 | Needham | Buy |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-12-22 | 개시 | Evercore ISI | In-line |
| 2020-12-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | 개시 | Goldman | Neutral |
| 2020-11-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | 개시 | DA Davidson | Buy |
| 2020-09-02 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-17 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | 개시 | Citigroup | Buy |
| 2020-07-13 | 개시 | Argus | Buy |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-04-30 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | 개시 | SVB Leerink | Outperform |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-25 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2020-03-16 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | 개시 | UBS | Neutral |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
텔라닥 헬스 주식(TDOC)의 최신 뉴스
5 Best Telemedicine and Telehealth Stocks for 2026 and How to Invest - The Motley Fool
Healthcare giants team up for new adolescent behavioral care initiative - AOL.com
Truist Securities Adjusts Price Target on Teladoc Health to $8 From $9, Keeps Hold Rating - marketscreener.com
Teladoc Health (TDOC) Could Be 55% Undervalued On Board Change And 2026 Guidance - Sahm
Teladoc's David B. Snow, Jr. to Retire from Board on Sept 30, 2026 - TradingView
Teladoc Health, Inc. (TDOC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teladoc Health, Inc. (TDOC) And Encourages Shareholders to Reach Out - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - natlawreview.com
Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Catapano Joseph Ronald - moomoo.com
Teladoc Health (TDOC) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teladoc Health, Inc. (TDOC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Teladoc Health | 8-K: Current report - moomoo.com
Teladoc Health, Inc. Stock 12‑Month Price Target Cut to $7.5, Implies 5% Upside - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teladoc Health, Inc. (TDOC) And Encourages Investors to Connect - ACCESS Newswire
Teladoc Health Inc (TDOC) Stock Analysis & Forecast - TradingKey
Teladoc Health Inc (TDOC) Stock News Today - TradingKey
Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript - AOL.com
Teladoc Health, Inc. (TDOC) options chain - Yahoo Finance Australia
Teladoc Health (TDOC) Securities Investigation NoticeLevi & Korsinsky - Morningstar
Teladoc Health Inc (TDOC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bronstein, Gewirtz & Grossman, LLC Encourages Teladoc Health, Inc. (TDOC) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - The AI Journal
Bronstein, Gewirtz & Grossman, LLC Encourages Teladoc Health, Inc. (TDOC) Investors to Inquire about Securities Investigation - ACCESS Newswire
Dimensional Fund Advisors LP Decreases Stake in Teladoc Health, Inc. $TDOC - MarketBeat
Director Mark V. Anquillare gets 37,425 RSUs at Teladoc Health (TDOC) - Stock Titan
Teladoc Health (NYSE: TDOC) director Mark Anquillare submits initial Form 3 - Stock Titan
Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a 16% Upside Potential Amidst Revenue Challenges - DirectorsTalk Interviews
Teladoc Health, Inc. Announces Appointment of Mark V. Anquillare to its Board of Directors and on the Board?s Audit & Compensation Committees, Effective August 3, 2026 - marketscreener.com
TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health - Morningstar
Teladoc Health adds former Verisk Analytics exec to board - Investing.com
Teladoc Health (TDOC) Is Down 23.5% After Weak Q2 And Lower 2026 Guidance Has The Bull Case Changed? - Sahm
Teladoc Health Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Teladoc Health, Inc. (NYSE:TDOC) Given Average Rating of "Hold" by Analysts - MarketBeat
Why Teladoc Health Stock Is Dropping Thursday Following Soft Q3 Outlook - TradingView
Teladoc Health, Inc. Stock 12‑Month Price Target Raised to $7.84, Implies 15% Downside - tradingview.com
Teladoc Health (TDOC) Stock Price Cracks As BetterHelp Reset Deepens - Sahm
Teladoc Health, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2026 - marketscreener.com
Teladoc Health (NYSE:TDOC) Issues FY 2026 Earnings Guidance - MarketBeat
Seeking Clues to Teladoc (TDOC) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance
Teladoc (TDOC) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Here's what to expect from Teladoc Health's Q2 print - Seeking Alpha
Discipline and Rules-Based Execution in TDOC Response - Stock Traders Daily
Teladoc Health Launches Person-Centered Virtual Care Platform for Connected Care - HLTH
Teladoc Health Canada Achieves Accreditation Canada Primer Award, Advancing Quality Standards for Virtual and Hybrid Care in Canada - Business Wire
Teladoc Health Inc (TDOC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Teladoc Health Inc (TDOC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TDOC|Teladoc Health Inc|Price:8.770|Chg%:+0.115 - TradingKey
Teladoc Health Inc (TDOC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Teladoc Health Inc (TDOC) Institutional Confidence - TradingKey
Teladoc Health Inc (TDOC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
텔라닥 헬스 (TDOC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
6.73%
자본화:
|
볼륨(24시간):